These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28035370)

  • 1. Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.
    Ohkoshi E; Umemura N
    Int J Oncol; 2017 Feb; 50(2):387-395. PubMed ID: 28035370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.
    Chikamatsu K; Ishii H; Takahashi G; Okamoto A; Moriyama M; Sakakura K; Masuyama K
    Head Neck; 2012 Mar; 34(3):336-43. PubMed ID: 21472882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients.
    Gammon L; Biddle A; Fazil B; Harper L; Mackenzie IC
    J Oral Pathol Med; 2011 Feb; 40(2):143-52. PubMed ID: 21138479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
    Emich H; Chapireau D; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
    Murillo-Sauca O; Chung MK; Shin JH; Karamboulas C; Kwok S; Jung YH; Oakley R; Tysome JR; Farnebo LO; Kaplan MJ; Sirjani D; Divi V; Holsinger FC; Tomeh C; Nichols A; Le QT; Colevas AD; Kong CS; Uppaluri R; Lewis JS; Ailles LE; Sunwoo JB
    Oncotarget; 2014 Aug; 5(16):6854-66. PubMed ID: 25149537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line.
    Ketkaew Y; Osathanon T; Pavasant P; Sooampon S
    Arch Oral Biol; 2017 Feb; 74():69-74. PubMed ID: 27886571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
    Khammanivong A; Gopalakrishnan R; Dickerson EB
    Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
    Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
    Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
    Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
    Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
    Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
    J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and genomic characterization of stem cells in head and neck cancer.
    Wilson GD; Marples B; Galoforo S; Geddes TJ; Thibodeau BJ; Grénman R; Akervall J
    Head Neck; 2013 Nov; 35(11):1573-82. PubMed ID: 23108794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
    Ludwig N; Szczepanski MJ; Gluszko A; Szafarowski T; Azambuja JH; Dolg L; Gellrich NC; Kampmann A; Whiteside TL; Zimmerer RM
    Cancer Lett; 2019 Dec; 467():85-95. PubMed ID: 31593802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.